Search Results - "DE FARIA GROSSI, Maria Aparecida"

Refine Results
  1. 1

    Risk factors for physical disability upon release from multidrug therapy in new cases of leprosy at a referral center in Brazil by Assis, Bárbara Proença Nardi, Lyon, Sandra, Grossi, Maria Aparecida de Faria, Rocha, Manoel Otávio da Costa

    “…The present study sought to investigate the risk factors for physical disability upon release from multidrug therapy (MDT) in new cases of leprosy, registered…”
    Get full text
    Journal Article
  2. 2

    Reading of the Mitsuda test: comparison between diameter and total area by means of a computerized method by Alecrim, Edilamar Silva de, Chaves, Ana Thereza, Pôrto, Luiz Alberto Bomjardim, Grossi, Maria Aparecida de Faria, Lyon, Sandra, Rocha, Manoel Otávio da Costa

    “…The Mitsuda test is a skin test based on the individual's immune response through late and highly specific hypersensitivity reaction to the Mycobacterium…”
    Get full text
    Journal Article
  3. 3

    Country profile: leprosy in Brazil by Penna, Maria Lucia Fernandes, Grossi, Maria Aparecida De Faria, Penna, Gerson Oliveira

    Published in Leprosy review (01-12-2013)
    “…Brazil has high rates of leprosy case detection, especially in the northern and west-central areas of the country. Effective decentralisation of routine…”
    Get full text
    Journal Article
  4. 4

    Hansen's disease: a vanishing disease? by Talhari, Sinésio, Grossi, Maria Aparecida de Faria, de Oliveira, Maria Leide WDR, Gontijo, Bernardo, Talhari, Carolina, Penna, Gerson Oliveira

    Published in Memórias do Instituto Oswaldo Cruz (01-12-2012)
    “…The introduction, implementation, successes and failures of multidrug therapy (MDT) in all Hansen's disease endemic countries are discussed in this paper. The…”
    Get full text
    Journal Article
  5. 5

    A Delphi exercise to refine the WHO three-point disability grading system for leprosy, and to develop guidelines to promote greater accuracy and reliability of WHO disability recording by Cross, Hugh

    Published in Leprosy review (01-03-2014)
    “…A Delphi Exercise was undertaken with two objectives: (1) To ascertain whether operational definitions for WHO Disability Grading could be formulated by…”
    Get full text
    Journal Article Conference Proceeding
  6. 6
  7. 7
  8. 8

    Associations between occupation, leprosy disability and other sociodemographic factors in an endemic area of Brazil by Cisneros, Juan, Ferreira, José Antonio, de Faria Grossi, Maria Aparecida, de Filippis, Thelma, de Oliveira, Ana Laura Grossi, Lyon, Sandra, Fairley, Jessica K

    Published in PLOS global public health (2022)
    “…In Brazil, new leprosy cases with grade-2 disability (G2D) have been increasing. Physical disability has been associated with experienced stigmatization,…”
    Get full text
    Journal Article
  9. 9

    Leprosy control: knowledge shall not be neglected by Penna, Maria Lúcia Fernandes, Temporão, Jose Gomes, Grossi, Maria Aparecida de Faria, Penna, Gerson Oliveira

    “…Better knowledge of transmission mechanisms is still needed to support a control strategy with important impact on Mycobacterium leprae transmission. Besides…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Evaluation of Leprosy Surveillance System in the Amazon region, Brazil, 2001―2007 by DE MELLO FREITAS, Felipe Teixeira, DE SENA NETO, Sebastião Alves, DE FARIA GROSSI, Maria Aparecida, MARQUES MACARIO, Eduardo, DA NOBREGA, Aglaer Alves

    Published in Leprosy review (01-03-2012)
    “…We evaluated the leprosy surveillance system in the Amazon region, Brazil, 2001-2007, using evaluation guidelines from the US Centers for Disease Control and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Seroprevalence of ML Flow test in leprosy contacts from State of Minas Gerais, Brazil by Andrade, Ana Regina Coelho de, Grossi, Maria Aparecida de Faria, Bührer-Sékula, Samira, Antunes, Carlos Maurício Figueiredo

    “…Leprosy is a public health problem in Brazil. Epidemiological control actions are based on the diagnosis and treatment of leprosy patients and household…”
    Get full text
    Journal Article
  14. 14

    Leprosy control strategies and the integration of health services: an international perspective by Visschedijk, Jan, Engelhard, Anrik, Lever, Peter, Grossi, Maria Aparecida de Faria, Feenstra, Pieter

    Published in Cadernos de saúde pública (2003)
    “…Integration of leprosy services into the general health services is regarded as the core strategy to ensure that leprosy control remains cost-effective and…”
    Get full text
    Journal Article
  15. 15

    A comparison of ML Flow serology and slit skin smears to assess the bacterial load in newly diagnosed leprosy patients in Brazil by LYON, Sandra, LYON, Ana Claudia, CASTORINA DA SILVA, Rozana, DE FARIA GROSSI, Maria Aparecida, LYON, Silvia Helena, BÜHRER-SEKULA, Samira, ROCHA, Manoel O. C

    Published in Leprosy review (01-06-2008)
    “…The ML Flow test is an immunochromatographic assay that detects IgM antibodies against M. leprae-specific anti-phenolic glycolipid I (PGL-I). In addition to…”
    Get full text
    Journal Article
  16. 16

    The influence of ML Flow test in leprosy classification by Grossi, Maria Aparecida de Faria, Leboeuf, Maria Ana Araújo, Andrade, Ana Regina Coelho de, Lyon, Sandra, Antunes, Carlos Maurício de Figueiredo, Bührer-Sékula, Samira

    “…This is a descriptive, exploratory study correlating ML Flow, bacilloscopy and classification of paucibacillary (PB) and multibacillary (MB), involving 1,041…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Risk factors for ML Flow seropositivity in leprosy patients by Grossi, Maria Aparecida de Faria, Leboeuf, Maria Ana Araújo, Andrade, Ana Regina Coelho de, Bührer-Sékula, Samira, Antunes, Carlos Maurício de Figueiredo

    “…The early diagnosis of leprosy, its correct classification and the risk factors related to seropositivity have become important for patient treatment and…”
    Get full text
    Journal Article
  19. 19

    Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15 by Saunderson, P., Kai, M., Suffys, P., Rosa, P.S., Williams, D., Gupta, U.D., Lavania, M., Cardona-Castro, N., Miyamoto, Y., Vissa, V., Johnson, R.C., Cauchoix, B., Cooreman, E.A.W.D., Pemmaraju, V.R.R., Gillini, L., Al-Samie, Abdul Rahim, Issoufou, Ahamed, Tiendrebeogo, Alexandre, Kingalu, AmriMiraju, Randrianantoandro, Andriamira, Kumar, Anil, Chauffour, Aurelie, Win, Aye Aye, Pandey, Basudev, Agrawal, C.M., Widaningrum, Christiana, Sema, Cynthia, Vidanagama, D.S., Scollard, David M., Beyene, Demmissew, Morelo, Eliane Faria, Kassa, Elizabeth Dizaneh, Claco, Eric, Villalon, Ernesto ES, Sidibe, Famoussa, Sakho, Fatoumata, Abdoulaye, Fomba, Guilengue, Francisco F., Babu, Gadde Rajan, Thakur, Garib Das, Cabanos, Gemma, Clugston, Greame, Zaidy, Hany, Watanabe, Haruo, Kawuma, Herman Joseph, Mallari, Irene Balenton, Goulart, Isabella Maria Bernandes, Ahamed, Issoufou, Subbanna, J., Luengu, Jean Norbert Mputu, Bertolli, Jeanne, Lloyd-Owen, Jonathan, Matheu, Jorge, Brunelli, José Pereira, Osuga, Katsunori, Yamaguchi, Kazuko, Azam, Khalid, Momoudu, Kodia, Doanh, Le Huu, My, Ley Huyen, Shah, Mahesh, Sidibe, Mamadou, Ebenezer, Mannam, Grossi, Maria Aparecida de Faria, Balagon, Marivic F., Canlonon, Marlience, Ahmed, Md Jamsheed, Roferos, Florenda Orcullo, Krismawati, Hana, Htoon, Myo Thet, Van, NguyenThi Hai, Hai, Ngyuen Phuc Nhu, Ishii, Norisha, Soe, Oke, Amiel, Olga, Tossou, Omar, Joshi, P.L., Ranganadha Rao, P.V., Krishnamurthy, Padebettu, Brennan, Patrick J., Busso, Phillipe, Rakoto Andrianarivelo, Mala, Ramdas, D.R., Chabi, Raoul, Gusmao, Renato, DjupuriIzwardy, Rita, Soares, Rosa Castalia Franca Riberio, Buhrer, Samira, Cho, Sang-Nae Ray, Lzumi, Shinzo, Barua, Sumana, Chaitanya, Sundeep, Khang, Tan Hau, Vijayalakshmi, V., Kamara, Vedastus Deusdedit, Wei, Wang, Smith, W.Cairn S., Li, Wei, Lew, Woojin, Al-Qubati, Yasin

    Published in Clinical microbiology and infection (01-12-2018)
    “…Antimicrobial resistance (AMR) is a priority for surveillance in bacterial infections. For leprosy, AMR has not been assessed because Mycobacterium leprae does…”
    Get full text
    Journal Article
  20. 20